ImmunoGen Inc.

NASDAQ: IMGN · Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM

ImmunoGen Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-222.93M -222.93M
Depreciation & Amortization
1.78M 1.78M
Stock-Based Compensation
25.61M 25.61M
Other Working Capital
-28.01M -28.01M
Other Non-Cash Items
-8.67M -8.67M
Deferred Income Tax
n/a n/a
Change in Working Capital
-25.6M -25.6M
Operating Cash Flow
-229.8M -229.8M
Capital Expenditures
-1.36M -1.36M
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a n/a
Investing Cash Flow
-1.36M -1.36M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
27.55M 355.74M
Financial Cash Flow
27.55M 355.74M
Net Cash Flow
-203.61M -203.61M
Free Cash Flow
-231.17M -231.17M